[The treatment of cerebrovascular insufficiency. Their evaluation in a double-blind study].
D000368:Aged; D000375:Aging; D002561:Cerebrovascular Disorders / Q000628:therapy*; D002986:Clinical Trials as Topic; D003221:Confusion / Q000188:drug therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D004928:Escin / Q000627:therapeutic use*; D006261:Headache / Q000188:drug therapy; D006801:Humans; D008569:Memory Disorders / Q000188:drug therapy; D010208:Papaverine / Q000627:therapeutic use*; D012503:Saponins / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy; D014717:Vertigo / Q000188:drug therapy
D004338:Drug Combinations; D012503:Saponins; D004928:Escin; D010208:Papaverine
Die Behandlung zerebrovaskulärer Insuffizienz. Ihre Beurteilung im Doppelblindversuch